Endoscopic removal vs surgery for early stomach cancer type
Part of Cancer, Digestive system clinical trials.
This trial compares two ways to treat early stomach cancer: removing it through an endoscope versus doing an operation. It’s meant for a specific stomach-cancer type (undifferentiated) that has not spread, to see which approach may be better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early stomach cancer of the undifferentiated type (signet ring cell, poorly differentiated tubular type, or poorly cohesive cancer).
- Your tumor is only in the inner lining of the stomach (mucosa), has no ulcer, and is 2 cm or smaller on endoscopy.
- Your scans (abdominal CT) show no spread to lymph nodes or distant organs.
- You are an adult between 19 and 75 years old.
- You can sign informed consent and are able to follow the study.
- You do not have certain exclusions: no prior stomach/food-pipe surgery, no multiple stomach cancers, and no other active cancer treatments in the last 5 years (with limited exceptions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat early stomach cancer: removing it with a scope (endoscopic submucosal dissection) or with surgery. It aims to see which method works better and has fewer side effects.
This study tests a less invasive surgery for early stomach cancer that combines a camera in the belly with a scope down the throat. It aims to remove the cancer while saving as much of the stomach as possible, which may mean a quicker recovery and better quality of life.
This trial studies how safe and effective a procedure called endoscopic submucosal dissection (ESD) is for treating certain early, superficial stomach (gastric) growths. It may be an option if your growth fits the endoscopy criteria and you are not a good candidate for stomach surgery.
This study compares two approaches after a non-curative ESD for early stomach cancer: one that removes sentinel lymph nodes (the first nodes where cancer might spread) and one that does not. Participating may help find out if removing these nodes improves outcomes.
This trial tests a robotic-assisted endoscope (a thin, flexible tube with a camera) to remove early-stage tumors from the stomach, colon, or rectum without major surgery. It aims to see if this new robotic method is safe and effective.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
Hear when a new Stomach Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.